Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 2 $ 126,626 $ (42,172) $ 84,456
Balance (in Shares) at Dec. 31, 2019 22,862,835      
Exercise of stock options [1] 106 106
Exercise of stock options (in Shares) 57,325      
Stock-based compensation expenses 337 337
Net loss (5,901) (5,901)
Balance at Mar. 31, 2020 $ 2 127,069 (48,073) 78,998
Balance (in Shares) at Mar. 31, 2020 22,920,160      
Balance at Dec. 31, 2020 $ 2 129,725 (72,258) 57,469
Balance (in Shares) at Dec. 31, 2020 23,264,637      
Exercise of stock options [1] 23 23
Exercise of stock options (in Shares) 12,646      
Exercise of warrants [2] [1]
Exercise of warrants (in Shares) [2] 362,383      
Issuance of Common Stock under Open Market Sales Agreement, net of $134 issuance costs [1] 4,334 4,334
Issuance of Common Stock under Open Market Sales Agreement, net of $134 issuance costs (in Shares) 601,674      
Stock-based compensation expenses 530 530
Net loss (8,402) (8,402)
Balance at Mar. 31, 2021 $ 2 $ 134,612 $ (80,660) $ 53,954
Balance (in Shares) at Mar. 31, 2021 24,241,340      
[1] Less than $1.
[2] See Note 5B.